Recent
March 26, 2024
COVID-19
October 19, 2022
Presented by: Mark Hyman, MD
Science in its purest form should be able to answer hypotheses and prove or disprove them. Research should be well designed, free of bias or conflicts of interest. Today’s competing nutrition paradigms leaves scientists, practitioners
Dr. Parker provides detailed description of how to create group visits that are personalized and comprehensive in covering lifestyle topics and the clinical imbalances of the Functional Medicine Matrix, while also focusing on scaled impacts on public health.
“Enteric Dialysis®” – To Delay the Need for Dialysis
Presented by: Mark Hyman, MD
Why are there so many different views on a healthy diet? Should your diet be plant-based, vegan, Paleo, raw, or any other of the dozens of diets that are promoted as healthy? The science of nutrition is fraught with methodological challenges. The politics of food and our lack of a coherent food policy compound the problem.
This edition of the Integrative Practitioner Digital Summit focuses on clinical nutrition.
Presented by: Marcelle Pick, NP, OB/GYN
Adrenal issues are more and more accepted in the functional
Presented by: Wendy Warner, MD, FACOG, ABIHM, IFMCP
Many of our patients already have had genetic testing done in order to understand their own SNPs (single nucleotide polymorphisms or “snips”). We can use this information to more easily tailor our plans for hormone balancing in women, ‘cutting to the chase’ so that each plan conforms to the individual we’re working with.
Presented by: Geri Brewster, RD, MPH, CDN, and Stephen Cowan, MD
Emerging research in epigenetics and nutrition is catching up to the ancient wisdom of Chinese medicine that conceptualized a unity of function between nervous system, digestion and immune resilience. This session will discuss the relevance of optimizing neuro-gastro-immune unity before, during, and after pregnancy in quality of long-term health. Using case studies, practical applications that employ both functional medicine and Chinese medicine will be discussed.
This issue highlights clinical advances in integrative medicine from the past year, and updates on trending industry topics. Included in this issue:
Presented by: Donald Abrams, MD
Delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, was licensed and approved for the treatment of chemotherapy-induced nausea and vomiting in 1985. Due to the significant barriers to studying the potential therapeutic effects of the parent botanical, the medical literature does not support the strong anecdotal impression that cannabis itself is effective for this indication. Cannabis is also the only antiemetic agent that is also purported to be an appetite stimulant that is also a useful attribute in patients with malignant diagnoses.